114 related articles for article (PubMed ID: 6542050)
1. Adriamycin and cis-diamminedichloroplatinum in the treatment of metastatic endometrial adenocarcinoma.
Seltzer V; Vogl SE; Kaplan BH
Gynecol Oncol; 1984 Nov; 19(3):308-13. PubMed ID: 6542050
[TBL] [Abstract][Full Text] [Related]
2. Phase II trial of cisplatin, adriamycin, and etoposide for metastatic endometrial adenocarcinoma.
Piver MS; Fanning J; Baker TR
Am J Clin Oncol; 1991 Jun; 14(3):200-2. PubMed ID: 2031506
[TBL] [Abstract][Full Text] [Related]
3. [Combination chemotherapy using cyclophosphamide, adriamycin, and cisplatin in recurrent or advanced endometrial cancer--a preliminary report].
Baba S; Kashimura M; Shinohara M; Kusano S; Sasayama T; Hamasaki K
Gan No Rinsho; 1989 Feb; 35(3):371-7. PubMed ID: 2926985
[TBL] [Abstract][Full Text] [Related]
4. Use of cisplatin, doxorubicin, and cyclophosphamide to treat advanced and recurrent adenocarcinoma of the endometrium.
Hancock KC; Freedman RS; Edwards CL; Rutledge FN
Cancer Treat Rep; 1986 Jun; 70(6):789-91. PubMed ID: 3731140
[TBL] [Abstract][Full Text] [Related]
5. Prospective treatment of advanced or recurrent endometrial carcinoma with cisplatin, doxorubicin, and cyclophosphamide.
Burke TW; Stringer CA; Morris M; Freedman RS; Gershenson DM; Kavanagh JJ; Edwards CL
Gynecol Oncol; 1991 Mar; 40(3):264-7. PubMed ID: 2013451
[TBL] [Abstract][Full Text] [Related]
6. Doxorubicin-cisplatin-vinblastine combination chemotherapy of advanced endometrial carcinoma: a Southwest Oncology Group Study.
Alberts DS; Mason NL; O'Toole RV; Hilgers RD; Rivkin SE; Boutselis JG; Pugh RP; Vaitkevicius VK; Green JB; Oishi N
Gynecol Oncol; 1987 Feb; 26(2):193-201. PubMed ID: 3542743
[TBL] [Abstract][Full Text] [Related]
7. Treatment of advanced or recurrent endometrial adenocarcinoma with cyclophosphamide, doxorubicin, cis-Platinum, and megestrol acetate.
Lovecchio JL; Averette HE; Lichtinger M; Townsend PA; Girtanner RW; Fenton AN
Obstet Gynecol; 1984 Apr; 63(4):557-60. PubMed ID: 6538327
[TBL] [Abstract][Full Text] [Related]
8. A preliminary study of a combination chemotherapy with ifosfamide, adriamycin and cisplatin for endometrial carcinoma.
Nishida T; Nagasue N; Kishi N; Imaishi K; Tateno N; Matsumura T; Yakushiji M
Nihon Sanka Fujinka Gakkai Zasshi; 1988 Dec; 40(12):1883-8. PubMed ID: 3209914
[TBL] [Abstract][Full Text] [Related]
9. Cisplatin, doxorubicin, and cyclophosphamide chemotherapy for advanced endometrial carcinoma.
Turbow MM; Ballon SC; Sikic BI; Koretz MM
Cancer Treat Rep; 1985 May; 69(5):465-7. PubMed ID: 4039978
[TBL] [Abstract][Full Text] [Related]
10. Treatment of advanced endometrial carcinoma with cisplatin, cyclophosphamide and doxorubicin.
Deppe G; Lin Liu T
Acta Obstet Gynecol Scand; 1985; 64(1):83-4. PubMed ID: 4038840
[TBL] [Abstract][Full Text] [Related]
11. Treatment of advanced endometrial carcinoma with doxorubicin and cisplatin: effects on both untreated and previously treated patients.
Pasmantier MW; Coleman M; Silver RT; Mamaril AP; Quiguyan CC; Galindo A
Cancer Treat Rep; 1985 May; 69(5):539-42. PubMed ID: 4039980
[TBL] [Abstract][Full Text] [Related]
12. [A case of recurrent endometrial cancer (clear cell adenocarcinoma) remarkably responsive to combination chemotherapy containing cisplatin].
Kitayama S; Iwahashi M; Iwahashi M; Yamoto M; Nakano R
Gan To Kagaku Ryoho; 1989 May; 16(5):2099-101. PubMed ID: 2730095
[TBL] [Abstract][Full Text] [Related]
13. Treatment of recurrent and metastatic endometrial cancer with cisplatin, doxorubicin, cyclophosphamide, and megestrol acetate.
Hoffman MS; Roberts WS; Cavanagh D; Praphat H; Solomon P; Lyman GH
Gynecol Oncol; 1989 Oct; 35(1):75-7. PubMed ID: 2477317
[TBL] [Abstract][Full Text] [Related]
14. Uterine papillary serous carcinoma. Complete response to combination chemotherapy.
Fitzgerald D; Rosenthal S
Cancer; 1985 Sep; 56(5):1023-4. PubMed ID: 4040419
[TBL] [Abstract][Full Text] [Related]
15. Treatment of advanced or recurrent adenocarcinoma of the endometrium with doxorubicin and cyclophosphamide.
Campora E; Vidali A; Mammoliti S; Ragni N; Conte PF
Eur J Gynaecol Oncol; 1990; 11(3):181-3. PubMed ID: 2209636
[TBL] [Abstract][Full Text] [Related]
16. Combination chemotherapy for metastatic or recurrent adenocarcinoma of the cervix.
Kavanagh JJ; Gershenson D; Copeland L; Roberts WS
J Clin Oncol; 1987 Oct; 5(10):1621-3. PubMed ID: 3655859
[TBL] [Abstract][Full Text] [Related]
17. Multimodal treatment with doxorubicin, cisplatin, and ifosfamide for the treatment of advanced or metastatic uterine leiomyosarcoma: a unicentric experience.
Hadoux J; Rey A; Duvillard P; Lhommé C; Balleyguier C; Haie-Meder C; Morice P; Tazi Y; Leary A; Larue C; Pautier P
Int J Gynecol Cancer; 2015 Feb; 25(2):296-302. PubMed ID: 25581897
[TBL] [Abstract][Full Text] [Related]
18. [Sequential combination chemotherapy consisting of vincristine, peplomycin, methotrexate, cis-diamminedichloroplatinum (II) and adriamycin in urothelial cancer].
Konami T; Wakabayashi Y; Kim T; Ishida A; Arai Y; Konishi T; Pak K; Takeuchi H; Tomoyoshi T; Watanabe J
Hinyokika Kiyo; 1989 Feb; 35(2):231-7. PubMed ID: 2472048
[TBL] [Abstract][Full Text] [Related]
19. Phase II trial of doxorubicin, 5-fluorouracil, etoposide, and cisplatin in advanced or recurrent endometrial carcinoma.
Pierga JY; Diéras V; Beuzeboc P; Dorval T; Palangié T; Jouve M; Scholl SM; Garcia-Giralt E; Pouillart P
Gynecol Oncol; 1997 Aug; 66(2):246-9. PubMed ID: 9264570
[TBL] [Abstract][Full Text] [Related]
20. Phase II trial of combination chemotherapy with fluorouracil (F), doxorubicin (A), and cisplatin (P) (Fap) in hormonally resistant metastatic prostatic adenocarcinoma.
Lupera H; Droz JP; Piot G; Lapleige P; Fargeot P; Theodore C
Oncology; 1989; 46(6):372-4. PubMed ID: 2587004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
